No Data
No Data
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter of 2024 on Wednesday, August 7,
Insider Buyers Lose US$71k As Quantum-Si Sheds US$67m
The recent price decline of 36% in Quantum-Si incorporated's (NASDAQ:QSI) stock may have disappointed insiders who bought US$141.9k worth of shares at an average price of US$1.67 in the past 12 months
Quantum-Si Incorporated's (NASDAQ:QSI) Top Owners Are Individual Investors With 38% Stake, While 34% Is Held by Institutions
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, today announced a presentation by Gloria Sheynkman, Ph.D
Quantum-Si Announces Presentations at ASMS and ESHG
Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant
Quantum-Si Appoints New Chairperson With Biomedical Expertise
No Data